ProductsInsulin and analogues

Insulin degludec

Long-acting basal analogue, purity ≥ 99 %.

A long-acting analogue of human insulin: B30 threonine removed and a C16 fatty diacid joined to lysine B29 through an L-γ-glutamate linker. Made by recombinant expression in E. coli and chemical modification.

Chemical identity

Structure of Insulin degludec
Molecular weight
6104 g/mol
InChIKey
FYZPCMFQCNBYCY-WIWKJPBBSA-N
PubChem CID
118984462

Specification

Made byE. coli expression, then chemical modification
AppearanceWhite or almost white powder
Purity≥ 99 %
StandardCompany standard, to China IND requirements
Storage and transport−15 °C or below
Shelf life24 months (provisional)
Peptide map of our degludec against the originator.
Peptide map of our degludec against the originator.
  • China IND completed and clinical approval obtained.
  • Quality documents ready for a DMF filing.
  • For research use, or for export as raw powder for medicines.